肿瘤学营养：克服挑战，优化患者从康复到康复的旅程。

IF 3.2 Q2 ONCOLOGY

Oncology and Therapy Pub Date : 2025-07-11 DOI:10.1007/s40487-025-00358-y

Stanislaw Klek, Alessandro Laviano, Hervé Chrostek, Diana Cardenas

{"title":"肿瘤学营养：克服挑战，优化患者从康复到康复的旅程。","authors":"Stanislaw Klek, Alessandro Laviano, Hervé Chrostek, Diana Cardenas","doi":"10.1007/s40487-025-00358-y","DOIUrl":null,"url":null,"abstract":"Patients with cancer are likely to be more malnourished than patients treated in other specialties, with many remaining at high nutritional risk prior to surgery or medical treatment. Malnutrition in patients with cancer can result in suboptimal clinical outcomes, and is linked to post-operative complications and reduced mortality, along with increased dose-limiting and treatment side effects. In addition, many medical treatments have gastrointestinal side effects which can further compromise the nutritional status of the patient. However, early patient assessment and proactive management of malnutrition using medical nutrition can have a positive impact on a patient's physiological parameters and functional status, while helping to support their metabolic and dietary needs during their cancer journey. A European Masterclass for Nutrition in Oncology which brought together 50 practitioners, took place on 10-11 October 2024 in Prague, Czech Republic, and aimed to provide an overview of nutrition as the cornerstone of cancer treatment, the use of nutritional prehabilitation in surgery and medical oncology, and optimization of the patient journey with nutrition, including rehabilitation. This paper provides a summary of the content presented, along with insights gained from attendees during four interactive workshop sessions.","PeriodicalId":44205,"journal":{"name":"Oncology and Therapy","volume":" ","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Nutrition in Oncology: Overcoming Challenges to Optimize the Patient Journey from Prehabilitation to Rehabilitation.\",\"authors\":\"Stanislaw Klek, Alessandro Laviano, Hervé Chrostek, Diana Cardenas\",\"doi\":\"10.1007/s40487-025-00358-y\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Patients with cancer are likely to be more malnourished than patients treated in other specialties, with many remaining at high nutritional risk prior to surgery or medical treatment. Malnutrition in patients with cancer can result in suboptimal clinical outcomes, and is linked to post-operative complications and reduced mortality, along with increased dose-limiting and treatment side effects. In addition, many medical treatments have gastrointestinal side effects which can further compromise the nutritional status of the patient. However, early patient assessment and proactive management of malnutrition using medical nutrition can have a positive impact on a patient's physiological parameters and functional status, while helping to support their metabolic and dietary needs during their cancer journey. A European Masterclass for Nutrition in Oncology which brought together 50 practitioners, took place on 10-11 October 2024 in Prague, Czech Republic, and aimed to provide an overview of nutrition as the cornerstone of cancer treatment, the use of nutritional prehabilitation in surgery and medical oncology, and optimization of the patient journey with nutrition, including rehabilitation. This paper provides a summary of the content presented, along with insights gained from attendees during four interactive workshop sessions.\",\"PeriodicalId\":44205,\"journal\":{\"name\":\"Oncology and Therapy\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2025-07-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oncology and Therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s40487-025-00358-y\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncology and Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s40487-025-00358-y","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

癌症患者可能比其他专业的患者更营养不良，许多患者在手术或药物治疗前仍处于高营养风险中。癌症患者的营养不良可能导致不理想的临床结果，并与术后并发症和死亡率降低有关，同时还会增加剂量限制和治疗副作用。此外，许多药物治疗都有胃肠道副作用，这可能进一步损害患者的营养状况。然而，利用医学营养对营养不良进行早期患者评估和主动管理，可以对患者的生理参数和功能状态产生积极影响，同时有助于支持他们在癌症治疗过程中的代谢和饮食需求。欧洲肿瘤营养大师班于2024年10月10日至11日在捷克共和国布拉格举行，汇集了50名从业人员，旨在概述作为癌症治疗基石的营养，在外科和肿瘤学医学中使用营养预康复，以及优化患者的营养旅程，包括康复。本文提供了所呈现内容的摘要，以及在四个互动研讨会期间从与会者那里获得的见解。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Nutrition in Oncology: Overcoming Challenges to Optimize the Patient Journey from Prehabilitation to Rehabilitation.

Patients with cancer are likely to be more malnourished than patients treated in other specialties, with many remaining at high nutritional risk prior to surgery or medical treatment. Malnutrition in patients with cancer can result in suboptimal clinical outcomes, and is linked to post-operative complications and reduced mortality, along with increased dose-limiting and treatment side effects. In addition, many medical treatments have gastrointestinal side effects which can further compromise the nutritional status of the patient. However, early patient assessment and proactive management of malnutrition using medical nutrition can have a positive impact on a patient's physiological parameters and functional status, while helping to support their metabolic and dietary needs during their cancer journey. A European Masterclass for Nutrition in Oncology which brought together 50 practitioners, took place on 10-11 October 2024 in Prague, Czech Republic, and aimed to provide an overview of nutrition as the cornerstone of cancer treatment, the use of nutritional prehabilitation in surgery and medical oncology, and optimization of the patient journey with nutrition, including rehabilitation. This paper provides a summary of the content presented, along with insights gained from attendees during four interactive workshop sessions.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Oncology and Therapy ONCOLOGY-

CiteScore

3.40

自引率

0.00%

发文量

审稿时长

6 weeks

期刊介绍： Now indexed in PubMed Aims and Scope Oncology and Therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality pre-clinical, clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions (including devices) across all therapeutic areas. Studies relating to diagnostics and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged. The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Oncology and Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research. Rapid Publication The journal’s rapid publication timelines aim for a peer review decision within 2 weeks of submission. If an article is accepted it will be published online 3-4 weeks from acceptance. These rapid timelines are achieved through the combination of a dedicated in-house editorial team, who closely manage article workflow, and an extensive Editorial and Advisory Board who assist with rapid peer review. This allows the journal to support the rapid dissemination of research, whilst still providing robust peer review. Combined with the journal’s open access model this allows for the rapid and efficient communication of the latest research and reviews, allowing the advancement of clinical therapies. Personal Service The journal’s dedicated in-house editorial team offer a personal “concierge service” meaning that authors will always have a personal point of contact able to update them on the status of their manuscript. The editorial team check all manuscripts to ensure that articles conform to the most recent COPE, GPP and ICMJE publishing guidelines. This supports the publication of ethically sound and transparent research. We also encourage pre-submission enquiries and are always happy to provide a confidential assessment of manuscripts. Digital features and plain language summaries Oncology and Therapy offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by key summary points, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. If you consider that your paper would benefit from the inclusion of a digital feature, please let us know. Our editorial team are able to create high-quality slide decks and infographics in-house, and video abstracts through our partner Research Square, and would be happy to assist in any way we can. For further information about digital features, please contact the journal editor (see ‘Contact the Journal’ for email address), and see the ‘Guidelines for digital features and plain language summaries’ document under ‘Submission guidelines’. Preprints We encourage posting of preprints of primary research manuscripts on preprint servers, authors'' or institutional websites, and open communications between researchers whether on community preprint servers or preprint commenting platforms. Posting of preprints is not considered prior publication and will not jeopardize consideration in our journals. Please see here for further information on preprint sharing: https://www.springer.com/gp/authors-editors/journal-author/journal-author-helpdesk/submission/1302#c16721550 Peer Review Process Upon submission, manuscripts are assessed by the editorial team to ensure they fit within the aims and scope of the journal and are also checked for plagiarism. All suitable submissions are then subject to a comprehensive single-blind peer review. Reviewers are selected based on their relevant expertise and publication history in the subject area. The journal has an extensive pool of editorial and advisory board members who have been selected to assist with peer review based on the afore-mentioned criteria. At least two extensive reviews are required to make the editorial decision, with the exception of some article types such as Commentaries, Editorials and Letters which are generally reviewed by one member of the Editorial Board. Where reviewer recommendations are conflicted, the editorial board will be contacted for further advice and a presiding decision. Manuscripts are then either accepted, rejected or authors are required to make major or minor revisions (both reviewer comments and editorial comments may need to be addressed). Once a revised manuscript is re-submitted, it is assessed along with the responses to reviewer comments and if it has been adequately revised it will be accepted for publication. Accepted manuscripts are then copyedited and typeset by the production team before online publication. Appeals against decisions following peer review are considered on a case by case basis and should be sent to the journal editor. Copyright Oncology and Therapy''s content is published open access under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0 Publication Fees Upon acceptance of an article, authors will be required to pay the mandatory Rapid Service Fee of £3650/€4500/$5100. The journal will consider fee discounts for developing countries and this is decided on a case by case basis. Open Access All articles published by Oncology and Therapy are published open access Contact For more information about the journal, including pre-submission enquiries, please contact managing editor Lydia Alborn at lydia.alborn@springer.com.